Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study

BACKGROUND: Opioid use disorder (OUD) remains a major public health concern. Despite the use of medications for OUD such as buprenorphine, the current gold-standard treatment, relapse in the context of increased craving remains common. Cannabidiol (CBD) has been shown to reduce cue-induced craving i...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Joji, Martin, Bianca, Prostko, Sara, Chai, Peter R., Weiss, Roger D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462449/
https://www.ncbi.nlm.nih.gov/pubmed/36105269
http://dx.doi.org/10.1089/imr.2022.0070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462449/
https://www.ncbi.nlm.nih.gov/pubmed/36105269
http://dx.doi.org/10.1089/imr.2022.0070

Ejemplares similares